Infectious keratitis: Secreted bacterial proteins that mediate corneal damage

Journal of Ophthalmology

Volumn 2013, Issue , 2013, Pages

  Marquart, Mary E ^a   O'Callaghan, Richard J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884220770     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2013/369094     Document Type: Review

References (128)

1. Asbell P., Stenson S., Ulcerative keratitis. Survey of 30 years' laboratory experience. Archives of Ophthalmology 1982 100 1 77 80 2-s2.0-0020078192
2. Girgis D. O., Sloop G. D., Reed J. M., O'Callaghan R. J., A new topical model of Staphylococcus corneal infection in the mouse. Investigative Ophthalmology and Visual Science 2003 44 4 1591 1597 2-s2.0-0037377987 10.1167/iovs.02-0656
3. Salyers A. A., Whitt D. D., Bacterial Pathogenesis, a Molecular Approach 2002 2nd Washington, DC, USA ASM Press
4. Traidej M., Caballero A. R., Marquart M. E., Thibodeaux B. A., O'Callaghan R. J., Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Investigative Ophthalmology and Visual Science 2003 44 1 190 196 2-s2.0-0037251309 10.1167/iovs.02-0458
5. Thibodeaux B. A., Caballero A. R., Marquart M. E., Tommassen J., O'Callaghan R. J., Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Current Eye Research 2007 32 4 373 386 2-s2.0-34247382035 10.1080/02713680701244181
6. O'Callaghan R. J., Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998. Cornea 1999 18 5 532 537 2-s2.0-0032835780
7. Hobden J. A., Hill J. M., Engel L. S., O'Callaghan R. J., Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen. Antimicrobial Agents and Chemotherapy 1993 37 9 1856 1859 2-s2.0-0027254972
8. Hobden J. A., Engel L. S., Hill J. M., Callegan M. C., O'Callaghan R. J., Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Current Eye Research 1993 12 5 469 473 2-s2.0-0027301724
9. Thibodeaux B. A., Caballero A. R., Dajcs J. J., Marquart M. E., Engel L. S., O'Callaghan R. J., Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity. Ocular Immunology and Inflammation 2005 13 2-3 169 182 2-s2.0-25144513638 10.1080/09273940490518937
10. Ogushi Y., Eguchi H., Kuwahara T., Hayabuchi N., Kawabata M., Molecular genetic investigations of contaminated contact lens storage cases as reservoirs of Pseudomonas aeruginosa keratitis. Japanese Journal of Ophthalmology 2010 54 6 550 554 2-s2.0-78751639498 10.1007/s10384-010-0874-1
11. Poggio E. C., Glynn R. J., Schein O. D., Seddon J. M., Shannon M. J., Scardino V. A., Kenyon K. R., The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. New England Journal of Medicine 1989 321 12 779 783 2-s2.0-0024441105
12. Schein O. D., Poggio E. C., Ulcerative keratitis in contact lens wearers. Incidence and risk factors. Cornea 1990 9 supplement 1 S55 S58 2-s2.0-0025288318 10.1097/00003226-199010001-00022
13. Ramirez J. C., Fleiszig S. M., Sullivan A. B., Tam C., Borazani R., Evans D. J., Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU. Investigative Ophthalmology and Visual Science 2012 53 1 448 453 10.1167/iovs.11-8999
14. Twining S. S., Kirschner S. E., Mahnke L. A., Frank D. W., Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Investigative Ophthalmology and Visual Science 1993 34 9 2699 2712 2-s2.0-0027179622
15. Marquart M. E., Caballero A. R., Chomnawang M., Thibodeaux B. A., Twining S. S., O'Callaghan R. J., Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Investigative Ophthalmology and Visual Science 2005 46 10 3761 3768 2-s2.0-32944481690 10.1167/iovs.04-1483
16. Kida Y., Higashimoto Y., Inoue H., Shimizu T., Kuwano K., A novel secreted protease from Pseudomonas aeruginosa activates NF- B through protease-activated receptors. Cellular Microbiology 2008 10 7 1491 1504 2-s2.0-45249083027 10.1111/j.1462-5822.2008.01142.x
17. Nicas T. I., Iglewski B. H., Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa. Journal of Clinical Microbiology 1986 23 5 967 969 2-s2.0-0022574187
18. Matsumoto K., Shams N. B. K., Hanninen L. A., Kenyon K. R., Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. Investigative Ophthalmology and Visual Science 1993 34 6 1945 1953 2-s2.0-0027207492
19. Kessler E., Kennah H. E., Brown S. I., Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas. Investigative Ophthalmology and Visual Science 1977 16 6 488 497 2-s2.0-0017683484
20. White C. D., Alionte L. G., Cannon B. M., Caballero A. R., O'Callaghan R. J., Hobden J. A., Corneal virulence of LasA protease-deficient Pseudomonas aeruginosa PAO1. Cornea 2001 20 6 643 646 2-s2.0-0034894855 10.1097/00003226- 200108000-00017
21. Pillar C. M., Hazlett L. D., Hobden J. A., Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye. Current Eye Research 2000 21 3 730 739 2-s2.0-0034532021 10.1076/0271-3683(200009)21:3;1-R;FT730
22. Hobden J. A., Pseudomonas aeruginosa proteases and corneal virulence. DNA and Cell Biology 2002 21 5-6 391 396 2-s2.0-0036377848 10.1089/ 10445490260099674
23. Kernacki K. A., Hobden J. A., Hazlett L. D., Fridman R., Berk R. S., In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Investigative Ophthalmology and Visual Science 1995 36 7 1371 1378 2-s2.0-0029065412
24. Kida Y., Shimizu T., Kuwano K., Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice. Infection and Immunity 2011 79 1 211 219 2-s2.0-78650860726 10.1128/IAI.01053-10
25. Caballero A., Thibodeaux B., Marquart M., Traidej M., O'Callaghan R. J., Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other pseudomonas proteases. Investigative Ophthalmology and Visual Science 2004 45 2 522 530 2-s2.0-0942287242 10.1167/iovs.03-1050
26. Conibear T., Wilcox M., Flanagan J. R., Zhu H., Characterization of protease IV expression in Pseudomonas aeruginosa clinical isolates. Journal of Medical Microbiology 2012 61, part 2 180 190 10.1099/jmm.0.034561-0
27. Engel L. S., Hill J. M., Caballero A. R., Green L. C., O'Callaghan R. J., Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. Journal of Biological Chemistry 1998 273 27 16792 16797 2-s2.0-0032479154 10.1074/jbc.273.27.16792
28. Caballero A. R., Moreau J. M., Engel L. S., Marquart M. E., Hill J. M., O'Callaghan R. J., Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases. Analytical Biochemistry 2001 290 2 330 337 2-s2.0-0035869555 10.1006/abio.2001.4999
29. Malloy J. L., Veldhuizen R. A. W., Thibodeaux B. A., O'Callaghan R. J., Wright J. R., Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. American Journal of Physiology/Lung Cell Molecular Physiology 2005 288 2 L409 L418 2-s2.0-12144257634 10.1152/ajplung.00322.2004
30. Tang A., Marquart M. E., Fratkin J. D., McCormick C. C., Caballero A. R., Gatlin H. P., O'Callaghan R. J., Properties of PASP: a pseudomonas protease capable of mediating corneal erosions. Investigative Ophthalmology and Visual Science 2009 50 8 3794 3801 2-s2.0-68349104992 10.1167/iovs.08-3107
31. O'Callaghan R. J., Tang A., Marquart M. E., Caballero A. R., Pseudomonas aeruginosa Small Protease (PASP), a keratitis virulence factor. Investigative Ophthalmology and Visual Science 2012 53. E-abstract 6128
32. Al Otaibi A. G., Allam K., Damri A. J., Shamri A. A., Kalantan H., Mousa A., Childhood microbial keratitis. Oman Journal of Ophthalmology 2012 5 1 28 31 10.4103/0974-620X.94763
33. Bashir G., Shah A., Thokar M. A., Rashid S., Shakeel S., Bacterial and fungal profile of corneal ulcers-a prospective study. Indian Journal of Pathology and Microbiology 2005 48 2 273 277 2-s2.0-33746039751
34. Bharathi M. J., Ramakrishnan R., Vasu S., Meenakshi R., Palaniappan R., Aetiological diagnosis of microbial keratitis in South India-a study of 1618 cases. Indian Journal of Medical Microbiology 2002 20 1 19 24
35. Bharathi M. J., Ramakrishnan R., Vasu S., Meenakshi R., Shivkumar C., Palaniappan R., Epidemiology of bacterial keratitis in a referral centre in south India. Indian Journal of Medical Microbiology 2003 21 4 239 245 2-s2.0-0344393429
36. Bharathi M. J., Ramakrishnan R., Meenakshi R., Padmavathy S., Shivakumar C., Srinivasan M., Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiology 2007 14 2 61 69 2-s2.0-34247616006 10.1080/09286580601001347
37. Feilmeier M. R., Sivaraman K. R., Oliva M., Tabin G. C., Gurung R., Etiologic diagnosis of corneal ulceration at a Tertiary Eye Center in Kathmandu, Nepal. Cornea 2010 29 12 1380 1385 2-s2.0-78650512044 10.1097/ICO. 0b013e3181d92881
38. Furlanetto R. L., Andreo E. G. V., Finotti I. G. A., Arcieri E. S., Ferreira M. A., Rocha F. J., Epidemiology and etiologic diagnosis of infectious keratitis in Uberlandia, Brazil. European Journal of Ophthalmology 2010 20 3 498 503 2-s2.0-77952884365
39. Katiyar R., Deorukhkar S., Saini S., Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India. Singapore Medical Journal 2012 53 4 264 267
40. Bharathi M. J., Ramakrishnan R., Shivakumar C., Meenakshi R., Lionalraj D., Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian Journal of Ophthalmology 2010 58 6 497 507 2-s2.0-78149433167 10.4103/0301-4738.71678
41. Boonpasart S., Kasetsuwan N., Puangsricharern V., Pariyakanok L., Jittpoonkusol T., Infectious keratitis at King Chulalongkorn Memorial Hospital: a-12-year retrospective study of 391 cases. Journal of the Medical Association of Thailand 2002 85 supplement 1 S217 S230 2-s2.0-0036621885
42. Lalitha P., Srinivasan M., Manikandan P., Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases 2012 54 10 1381 1387 10.1093/cid/cis189
43. Norina T. J., Raihan S., Bakiah S., Ezanee M., Liza-Sharmini A. T., Wan Hazzabah W. H., Microbial keratitis: aetiological diagnosis and clinical features in patients admitted to Hospital Universiti Sains Malaysia. Singapore Medical Journal 2008 49 1 67 71 2-s2.0-39049138303
44. Ramesh S., Ramakrishnan R., Bharathi M. J., Amuthan M., Viswanathan S., Prevalence of bacterial pathogens causing ocular infections in South India. Indian Journal of Pathology and Microbiology 2010 53 2 281 286 2-s2.0-77953932328 10.4103/0377-4929.64336
45. Schaefer F., Bruttin O., Zografos L., Guex-Crosier Y., Bacterial keratitis: a prospective clinical and microbiological study. British Journal of Ophthalmology 2001 85 7 842 847 2-s2.0-0034925204 10.1136/bjo.85.7.842
46. Shalchi Z., Gurbaxani A., Baker M., Nash J., Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom. Ophthalmology 2011 118 11 2161 2165 10.1016/j.ophtha.2011.04.021
47. Varaprasathan G., Miller K., Lietman T., Whitcher J. P., Cevallos V., Okumoto M., Margolis T. P., Yinghui M., Cunningham E. T., Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea 2004 23 4 360 364 2-s2.0-2142717422 10.1097/00003226-200405000-00009
48. Wagoner M. D., Al-Swailem S. A., Sutphin J. E., Zimmerman M. B., Bacterial keratitis after penetrating keratoplasty. Incidence, microbiological profile, graft survival, and visual outcome. Ophthalmology 2007 114 6 1073 1079 2-s2.0-34248532062 10.1016/j.ophtha.2006.10.015
49. Yilmaz S., Ozturk I., Maden A., Microbial keratitis in West Anatolia, Turkey: a retrospective review. International Ophthalmology 2007 27 4 261 268 2-s2.0-34447103498 10.1007/s10792-007-9069-2
50. Cosar C. B., Cohen E. J., Rapuano C. J., Laibson P. R., Clear corneal wound infection after phacoemulsification. Archives of Ophthalmology 2001 119 12 1755 1759 2-s2.0-0035208283
51. Lifshitz T., Levy J., Raiskup F., Klemperer I., Frucht-Pery J., Two cases of pneumococcal keratitis following myopic LASIK. Journal of Refractive Surgery 2005 21 5 498 501 2-s2.0-25144505985
52. Mulet M. E., Pérez-Santonja J. J., Ferrer C., Alió J. L., Microbial keratitis after intrastromal corneal ring segment implantation. Journal of Refractive Surgery 2010 26 5 364 369 2-s2.0-77953052815 10.3928/1081597X-20090617-06
53. Nubile M., Carpineto P., Lanzini M., Ciancaglini M., Zuppardi E., Mastropasqua L., Multilayer amniotic membrane transplantation for bacterial keratitis with corneal perforation after hyperopic photorefractive keratectomy. Case report and literature review. Journal of Cataract and Refractive Surgery 2007 33 9 1636 1640 2-s2.0-34548022344 10.1016/j.jcrs.2007.04.040
54. Rehany U., Balut G., Lefler E., Rumelt S., The prevalence and risk factors for donor corneal button contamination and its association with ocular infection after transplantation. Cornea 2004 23 7 649 654 2-s2.0-4744349083 10.1097/01.ico.0000139633.50035.cf
55. Griffith F., The significance of pneumococcal types. Journal of Hygiene 1928 27 2 113 159 10.1017/S0022172400031879
56. Avery O. T., MacLeod C. M., McCarty M., Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. Journal of Experimental Medicine 1944 79 1 137 158
57. Norcross E. W., Tullos N. A., Taylor S. D., Sanders M. E., Marquart M. E., Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection. Current Eye Research 2010 35 9 787 798 2-s2.0-77956167217 10.3109/02713683.2010.492462
58. Reed J. M., O'Callaghan R. J., Girgis D. O., McCormick C. C., Caballero A. R., Marquart M. E., Ocular virulence of capsule-deficient Streptococcus pneumoniae in a rabbit keratitis model. Investigative Ophthalmology and Visual Science 2005 46 2 604 608 2-s2.0-13944281686 10.1167/iovs.04-0889
59. Johnson M. K., Cellular location of pneumolysin. FEMS Microbiology Letters 1977 2 5 243 245 2-s2.0-0017661629 10.1016/0378-1097(77)90017-9
60. Kanclerski K., Möllby R., Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). Journal of Clinical Microbiology 1987 25 2 222 225 2-s2.0-0023068574
61. Steinfort C., Wilson R., Mitchell T., Feldman C., Rutman A., Todd H., Sykes D., Walker J., Saunders K., Andrew P. W., Boulnois G. J., Cole P. J., Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infection and Immunity 1989 57 7 2006 2013 2-s2.0-0024327677
62. Price K. E., Camilli A., Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. Journal of Bacteriology 2009 191 7 2163 2168 2-s2.0-64049092852 10.1128/JB.01489-08
63. Morgan P. J., Hyman S. C., Byron O., Andrew P. W., Mitchell T. J., Rowe A. J., Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form. Journal of Biological Chemistry 1994 269 41 25315 25320 2-s2.0-0028062876
64. Morgan P. J., Hyman S. C., Rowe A. J., Mitchell T. J., Andrew P. W., Saibil H. R., Subunit organisation and symmetry of pore-forming, oligomeric pneumolysin. FEBS Letters 1995 371 1 77 80 2-s2.0-0029153944 10.1016/0014-5793(95)00887-F
65. Tilley S. J., Orlova E. V., Gilbert R. J. C., Andrew P. W., Saibil H. R., Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 2005 121 2 247 256 2-s2.0-17444405610 10.1016/j.cell.2005.02.033
66. Johnson M. K., Boese-Marrazzo D., Pierce W. A. Jr., Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infection and Immunity 1981 34 1 171 176 2-s2.0-0019389568
67. Paton J. C., Rowan Kelly B., Ferrante A., Activation of human complement by the pneumococcal toxin pneumolysin. Infection and Immunity 1984 43 3 1085 1087 2-s2.0-0021363204
68. Johnson M. K., Allen J. H., Ocular toxin of the pneumococcus. American Journal of Ophthalmology 1971 72 1 175 180 2-s2.0-0015245713
69. Johnson M. K., Allen J. H., The role of cytolysin in pneumococcal ocular infection. American Journal of Ophthalmology 1975 80 3, part 2 518 521 2-s2.0-0006227142
70. Johnson M. K., Hobden J. A., Hagenah M., O'Callaghan R. J., Hill J. M., Chen S., The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Current Eye Research 1990 9 11 1107 1114 2-s2.0-0025598036
71. Johnson M. K., Callegan M. C., Engel L. S., O'Callaghan R. J., Hill J. M., Hobden J. A., Boulnois G. J., Andrew P. W., Mitchell T. J., Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. Current Eye Research 1995 14 4 281 284 2-s2.0-0028898672
72. Harrison J. C., Karcioglu Z. A., Johnson M. K., Response of leukopenic rabbits to pneumococcal toxin. Current Eye Research 1982-1983 2 10 705 710 2-s2.0-0020439868
73. Green S. N., Sanders M., Moore Q. C. III, Norcross E. W., Monds K. S., Caballero A. R., McDaniel L. S., Robinson S. A., Onwubiko C., O'Callaghan R. J., Marquart M. E., Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Investigative Ophthalmology and Visual Science 2008 49 1 290 294 2-s2.0-39549086190 10.1167/iovs.07-0492
74. Moore Q. C. III, McCormick C. C., Norcross E. W., Onwubiko C., Sanders M. E., Fratkin J., McDaniel L. S., O'Callaghan R. J., Marquart M. E., Development of a Streptococcus pneumoniae keratitis model in mice. Ophthalmic Research 2009 42 3 141 146 2-s2.0-67651005204 10.1159/000229028
75. Johnson M. K., Geoffroy C., Alouf J. E., Binding of cholesterol by sulfhydryl-activated cytolysins. Infection and Immunity 1980 27 1 97 101 2-s2.0-0018917907
76. Marquart M. E., Monds K. S., McCormick C. C., Dixon S. N., Sanders M. E., Reed J. M., McDaniel L. S., Caballero A. R., O'Callaghan R. J., Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea. Investigative Ophthalmology and Visual Science 2007 48 6 2661 2666 2-s2.0-34347224405 10.1167/iovs.07-0017
77. Sanders M. E., Tullos N. A., Taylor S. D., Norcross E. W., King L. B., Tolo I., Marquart M. E., Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. Current Eye Research 2010 35 12 1142 1147 2-s2.0-78649745625 10.3109/02713683.2010.512114
78. Norcross E. W., Sanders M. E., Moore Q. C. III, Active immunization with pneumolysin versus 23-valent polysaccharide vaccine for Streptococcus pneumoniae keratitis. Investigative Ophthalmology and Visual Science 2011 52 12 9232 9243 10.1167/iovs.10-6968
79. Mitchell A. M., Mitchell T. J., Streptococcus pneumoniae: virulence factors and variation. Clinical Microbiology and Infection 2010 16 5 411 418 2-s2.0-77952903334 10.1111/j.1469-0691.2010.03183.x
80. Williamson Y. M., Gowrisankar R., Longo D. L., Facklam R., Gipson I. K., Ades E. P., Carlone G. M., Sampson J. S., Adherence of nontypeable Streptococcus pneumoniae to human conjunctival epithelial cells. Microbial Pathogenesis 2008 44 3 175 185 2-s2.0-38549141930 10.1016/j.micpath.2007.08.016
81. Govindarajan B., Menon B. B., Spurr-Michaud S., A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One 2012 7 3, article e32418
82. Liesegang T. J., Kaufman H. E., Baron B. A., McDonald M. A., Bacterial keratitis. The Cornea 1998 Boston, Mass, USA Butterworth-Heineman
83. Wong V. W., Lai T. Y., Chi S. C., Lam D. S., Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea 2011 30 9 995 1002 10.1097/ICO.0b013e31820770f4
84. Jeng B. H., Gritz D. C., Kumar A. B., Holsclaw D. S., Porco T. C., Smith S. D., Whitcher J. P., Margolis T. P., Wong I. G., Epidemiology of ulcerative keratitis in Northern California. Archives of Ophthalmology 2010 128 8 1022 1028 2-s2.0-77955459367 10.1001/archophthalmol.2010.144
85. Kerr N., Stern G. A., Bacterial keratitis associated with vernal keratoconjunctivitis. Cornea 1992 11 4 355 359 2-s2.0-0026741977 10.1097/00003226-199207000-00015
86. Palmer M. L., Hyndiuk R. A., Contact lens-related infectious keratitis. International Ophthalmology Clinics 1993 33 1 23 49 2-s2.0-0027414909
87. Sowka J. W., Gurwood A. S., Kabat A. G., Handbook of Ocular Disease Management Web Site: Bacterial Keratitis 2001 Jobson Publishing
88. Tacconelli E., Johnson A. P., National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands. The Journal of Antimicrobial Chemotherapy 2011 66 10 2195 2198 10.1093/jac/dkr309
89. Speaker M. G., Milch F. A., Shah M. K., Eisner W., Kreiswirth B. N., Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991 98 5 639 649 2-s2.0-0025875354
90. Köck R., Harlizius J., Bressan N., Laerberg R., Wieler L. H., Witte W., Deurenberg R. H., Voss A., Becker K., Friedrich A. W., Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. European Journal of Clinical Microbiology and Infectious Diseases 2009 28 11 1375 1382 2-s2.0-70449529647 10.1007/s10096-009-0795-4
91. Cheung J., Slomovic A. R., Microbial etiology and predisposing factors among patients hospitalized for corneal ulceration. Canadian Journal of Ophthalmology 1995 30 5 251 255 2-s2.0-0029160419
92. Ormerod L. D., Hertzmark E., Gomez D. S., Stabiner R. G., Schanzlin D. J., Smith R. E., Epidemiology of microbial keratitis in Southern California. A multivariate analysis. Ophthalmology 1987 94 10 1322 1333 2-s2.0-0023229989
93. Coster D. J., Badenoch P. R., Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. British Journal of Ophthalmology 1987 71 2 96 101 2-s2.0-0023148593
94. Asbell P. A., Sahm D. F., Shaw M., Draghi D. C., Brown N. P., Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. Journal of Cataract and Refractive Surgery 2008 34 5 814 818 2-s2.0-42949133281 10.1016/j.jcrs.2008. 01.016
95. Dave S. B., Toma H. S., Kim S. J., Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology 2011 118 10 2035 2040 10.1016/j.ophtha.2011.03.017
96. Morrissey I., Burnett R., Viljoen L., Robbins M., Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. The Journal of Infection 2004 49 2 109 114 2-s2.0-3242793435 10.1016/j.jinf.2004.03.007
97. McDonald M., Blondeau J. M., Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. Journal of Cataract and Refractive Surgery 2010 36 9 1588 1598 2-s2.0-77955589135 10.1016/j.jcrs.2010.06.028
98. Schmidt H., Hensel M., Pathogenicity islands in bacterial pathogenesis. Clinical Microbiology Reviews 2004 17 1 14 56 2-s2.0-1642475095 10.1128/CMR.17.1.14-56.2004
99. Enright M. C., Lindsay J. A., The population structure of Staphylococcus aureus. Staphylococcus Molecular Genetics 2008 Norfolk, UK Caister Academic Press 29 43
100. McAdam P. R., Templeton K. E., Edwards G. F., Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America 2012 109 23 9107 9112 10.1073/pnas.1202869109
101. Jett B. D., Gilmore M. S., Internalization of Staphylococcus aureus by human corneal epithelial cells: role of bacterial fibronectin-binding protein and host cell factors. Infection and Immunity 2002 70 8 4697 4700 2-s2.0-0036076014 10.1128/IAI.70.8.4697-4700.2002
102. Rhem M. N., Lech E. M., Patti J. M., McDevitt D., Höök M., Jones D. B., Wilhelmus K. R., The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis. Infection and Immunity 2000 68 6 3776 3779 2-s2.0-0034075296 10.1128/IAI.68.6.3776-3779.2000
103. Girgis D. O., Dajcs J. J., O'Callaghan R. J., Phospholipase A2 activity in normal and Staphylococcus aureus -infected rabbit eyes. Investigative Ophthalmology and Visual Science 2003 44 1 197 202 2-s2.0-0037207477 10.1167/iovs.02-0548
104. Moreau J. M., Girgis D. O., Hume E. B. H., Dajcs J. J., Austin M. S., O'Callaghan R. J., Phospholipase A2 in rabbit tears: a host defense against Staphylococcus aureus. Investigative Ophthalmology and Visual Science 2001 42 10 2347 2354 2-s2.0-0034848729
105. Hume E. B. H., Dajcs J. J., Moreau J. M., Sloop G. D., Willcox M. D. P., O'Callaghan R. J., Staphylococcus corneal virulence in a new topical model of infection. Investigative Ophthalmology and Visual Science 2001 42 12 2904 2908 2-s2.0-0034766175
106. O'Callaghan R. J., Callegan M. C., Moreau J. M., Green L. C., Foster T. J., Hartford O. M., Engel L. S., Hill J. M., Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infection and Immunity 1997 65 5 1571 1578 2-s2.0-0030934821
107. Moreau J. M., Sloop G. D., Engel L. S., Hill J. M., O'Callaghan R. J., Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. Current Eye Research 1997 16 12 1221 1228 2-s2.0-0030658774
108. Girgis D. O., Sloop G. D., Reed J. M., O'Callaghan R. J., A new topical model of Staphylococcus corneal infection in the mouse. Investigative Ophthalmology and Visual Science 2003 44 4 1591 1597 2-s2.0-0037377987 10.1167/iovs.02-0656
109. Girgis D. O., Sloop G. D., Reed J. M., O'Callaghan R. J., Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Investigative Ophthalmology and Visual Science 2005 46 6 2064 2070 2-s2.0-22144435951 10.1167/iovs.04-0897
110. Kebaier C., Chamberland R. C., Allen I. C., Staphylococcus aureus -hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. Journal of Infectious Diseases 2012 205 5 807 817 10.1093/infdis/jir846
111. Menestrina G., Serra M. D., Prévost G., Mode of action of β -barrel pore-forming toxins of the staphylococcal -hemolysin family. Toxicon 2001 39 11 1661 1672 2-s2.0-0034869444 10.1016/S0041-0101(01)00153-2
112. Pany S., Vijayvargia R., Krishnasastry M. V., Caveolin-1 binding motif of -hemolysin: its role in stability and pore formation. Biochemical and Biophysical Research Communications 2004 322 1 29 36 2-s2.0-4143063601 10.1016/j.bbrc.2004.07.073
113. Vijayvargia R., Suresh C. G., Krishnasastry M. V., Functional form of caveolin-1 is necessary for the assembly of -hemolysin. Biochemical and Biophysical Research Communications 2004 324 3 1130 1136 2-s2.0-5444262529 10.1016/j.bbrc.2004.09.164
114. McCormick C. C., Caballero A. R., Balzli C. L., Tang A., O'Callaghan R. J., Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. Investigative Ophthalmology and Visual Science 2009 50 6 2848 2854 2-s2.0-66849111209 10.1167/iovs.08-3157
115. Weeks A. C., Balzli C. L., Caballero A. R., Tang A., O'Callaghan R. J., Identification and potency of cyclodextrin-lipid inhibitors of Staphylococcus aureus -toxin. Current Eye Research 2012 37 2 87 93 10.3109/02713683.2011.624669
116. Freer J. H., Arbuthnott J. P., Toxins of Staphylococcus aureus. Pharmacology and Therapeutics 1982 19 1 55 106 2-s2.0-0020285081
117. Clyne M., De Azavedo J., Carlson E., Arbuthnott J., Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome. Journal of Clinical Microbiology 1988 26 3 535 539 2-s2.0-0023884065
118. Dajcs J. J., Austin M. S., Sloop G. D., Moreau J. M., Hume E. B. H., Thompson H. W., McAleese F. M., Foster T. J., O'Callaghan R. J., Corneal pathogenesis of Staphylococcus aureus strain Newman. Investigative Ophthalmology and Visual Science 2002 43 4 1109 1115 2-s2.0-0036202875
119. Supersac G., Piémont Y., Kubina M., Prévost G., Foster T. J., Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microbial Pathogenesis 1998 24 4 241 251 2-s2.0-0345487013 10.1006/mpat.1997.0192
120. Arana A. M., Balzli C. L., Weeks A. C., Tang A., Caballero A. R., O'Callaghan R. J., Pathogenesis of Staphylococcus aureus endophthalmitis: analysis of alpha-toxin and gamma-toxin in the rabbit anterior chamber. Investigative Ophthalmology & Visual Science 2012 53. E-abstract 2772
121. Yamashita K., Kawai Y., Tanaka Y., Crystal structure of the octameric pore of staphylococcal γ -hemolysin reveals the β -barrel pore formation mechanism by two component. Proceeding of the National Academy of Sciences of the United States of America 2011 108 42 17314 17319
122. Gravet A., Colin D. A., Keller D., Girardot R., Monteil H., Prevost G., Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Letters 1998 436 2 202 208 10.1016/S0014-5793(98)01130-2
123. Szmigieski S., Prevost G., Monteil H., Colin D. A., Jelaszewicz J., Leukocidal toxins of staphylococci. Zentralblatt für Bakteriologie 1999 289 2 185 201 10.1016/S0934-8840(99)80105-4
124. Sugawara N., Tomita T., Kamio Y., Assembly of Staphylococcus aureus γ -hemolysin into a pore-forming ring- shaped complex on the surface of human erythrocytes. FEBS Letters 1997 410 2-3 333 337 2-s2.0-0030740555 10.1016/S0014-5793(97)00618-2
125. Caballero A. R., Foster T. J., Monk I. R., Tang A., Balzli C. L., O'Callaghan R. J., Ocular pathology of a Staphylococcus aureus mutant lacking a recently discovered virulence factor. Investigative Ophthalmology and Visual Science 2010 51. E-abstract 3891
126. Fraser J. D., Proft T., The bacterial superantigen and superantigen-like proteins. Immunological Reviews 2008 225 1 226 243 2-s2.0-52049123299 10.1111/j.1600-065X.2008.00681.x
127. Caballero A. R., McCormick C. C., Tang A., O'Callaghan R. J., Isolation and characterization of a new Staphylococcus aureus protease. Investigative Ophthalmology and Visual Science 2008 49. abstract 5514
128. Balaban N., Novick R. P., Autocrine regulation of toxin synthesis by Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America 1995 92 5 1619 1623 2-s2.0-0028944117 10.1073/pnas.92.5.1619